MENU
+Compare
CNCR
ETF ticker: NASDAQ
AS OF
Jan 24, 02:11 PM (EDT)
Price
$12.59
Change
+$0.11 (+0.88%)
Net Assets
10.14M

CNCR stock forecast, quote, news & analysis

Category: @Health
CNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Ad is loading...
A.I.Advisor
a Summary for CNCR with price predictions
Jan 08, 2025

CNCR in +5.85% Uptrend, advancing for three consecutive days on January 03, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where CNCR advanced for three days, in of 278 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on January 03, 2025. You may want to consider a long position or call options on CNCR as a result. In of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CNCR just turned positive on December 31, 2024. Looking at past instances where CNCR's MACD turned positive, the stock continued to rise in of 57 cases over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 62 cases where CNCR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CNCR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Merck & Co (NYSE:MRK), Bristol-Myers Squibb Co (NYSE:BMY), Regeneron Pharmaceuticals (NASDAQ:REGN), Exelixis (NASDAQ:EXEL).

Industry description

The investment seeks to track the performance, before fees and expenses, of the Range Oncology Therapeutics Index. The index was established in 2023 by Range Fund Holdings and tracks the performance of a portfolio of U.S. exchange-listed pharmaceutical or biotechnology stocks or American Depositary Receipts (“ADRs”) with a market capitalization of more than $250 million. The advisor attempts to invest all, or substantially all, of its assets in the component securities that make up the index. Under normal circumstances, at least 80% of the fund’s total assets will be invested in the component securities of the index.

Market Cap

The average market capitalization across the Range Cancer Therapeutics ETF ETF is 8.96B. The market cap for tickers in the group ranges from 10.49M to 331.75B. MRK holds the highest valuation in this group at 331.75B. The lowest valued company is APLM at 10.49M.

High and low price notable news

The average weekly price growth across all stocks in the Range Cancer Therapeutics ETF ETF was 63%. For the same ETF, the average monthly price growth was 75%, and the average quarterly price growth was 139%. SMMT experienced the highest price growth at 36%, while MRSN experienced the biggest fall at -15%.

Volume

The average weekly volume growth across all stocks in the Range Cancer Therapeutics ETF ETF was -3%. For the same stocks of the ETF, the average monthly volume growth was 98% and the average quarterly volume growth was 31%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 51
P/E Growth Rating: 83
Price Growth Rating: 66
SMR Rating: 92
Profit Risk Rating: 92
Seasonality Score: 4 (-100 ... +100)
View a ticker or compare two or three
CNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
ETF Series Solutions615 East Michigan Street, Milwaukee, WisconsinEast Michigan
Phone
(414) 765-5586
Web
N/A